Latest News

The shocking part is that the gift is only a drop in the bucket compared to the founder's total wealth.

You don't have to wait until December to find out how much your Social Security check will grow.

Both stocks have soared in recent years.

Both of these biotech stocks could be appealing to income investors.

The AI software specialist is nearing a $10 billion year. Will its share price rise with its sales?

Amazon's stock popped after reporting strong AWS growth in Q2. I like the odds of history repeating.

Statistically speaking, tariffs have been bad news for Wall Street and consumers.

One class has a vote. Is that vote worth paying about 1% more for?

SpaceX’s AI business is booming. That has important implications for the broader industry.

There's a downside to a generous raise.

A bear market could be on the way, but the right strategy can protect your portfolio.

Capstone Energy+ (NASDAQ:CEPL) is positioning its distributed energy technology as a way to provide “energy certainty” for customers facing grid constraints, permitting delays and growing power needs, President and CEO Vince Canino said during a company presentation. Canino said businesses historic

Wealth and Trust fees surged 30% year-over-year as core EPS grew 25%.

Centrus Energy is the lone publicly traded U.S.-based uranium enricher.

Both automakers offer something different for potential investors.

It doesn't take huge sums of money to build a seven-figure investment portfolio.

Palvella Therapeutics (NASDAQ:PVLA) is preparing for a potential commercial launch of QTORIN rapamycin while advancing additional rare skin and vascular anomaly programs, Chief Financial Officer Matt Korenberg said during a Chardan investor session. Korenberg said the company has expanded from deve

Altria is typically an income play, but the cigarette giant has shown some growth characteristics this year.

Did the fund that beat the hedge funds keep that up after the bet was over?

There are hundreds of billions at stake and fears that AI spending is creating an unsustainable bubble.

OmniAb (NASDAQ:OABI) Chief Financial Officer Kurt Gustafson outlined the company’s antibody-discovery platform, partner pipeline and revenue model during a company presentation, emphasizing a strategy built around licensing technology to pharmaceutical and biotechnology companies rather than develop

Shares of Meta have dropped nearly 10% this week.

Property casualty insurer Cincinnati Financial (NASDAQ:CINF) will be announcing earnings results this Monday after market hours. Here’s what to look for. Cin...

Home appliances manufacturer Whirlpool (NYSE:WHR) will be reporting earnings this Monday after market close. Here’s what investors should know. Whirlpool mis...

U.S. citizens will head to the polls on Nov. 3 to vote in a slate of races in both the U.S. House of Representatives and the U.S. Senate.